Cryo-Cell International Receives FACT Re-accreditation, Setting the Longest Independently Validated Quality Track Record Among U.S. Private Cord Blood Banks
Cryo-Cell International, Inc. (CCEL)
NASDAQ:AMEX Investor Relations:
cryo-cell.com/investor-relations
Company Research
Source: Business Wire
OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world’s first private cord blood bank, has been granted renewed Foundation for the Accreditation of Cellular Therapy (“FACT”) Accreditation for Cord Blood Collection, Banking, and Release for Administration (Related and Unrelated) Donations. Originally accredited in 2014, the Company’s latest FACT re-accreditation extends for three more years, with the latest renewal effective through April 3, 2029.The FACT accreditation was issued after Cryo-Cell International, Inc. demonstrated compliance with the NetCord-FACT Standards for Cord Blood Banking — the most rigorous internationally recognized quality framework in cellular therapy.Accreditation Scope and VerificationThe FACT certificate confirms that Cryo-Cell International, Inc., having met the NetCord-FACT Standards for Cord Blood Banking, is granted FACT Accreditation for Cord Blood Collection, Banking, and Release for Admi
Show less
Read more
Impact Snapshot
Event Time:
CCEL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CCEL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CCEL alerts
High impacting Cryo-Cell International, Inc. news events
Weekly update
A roundup of the hottest topics
CCEL
News
- Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2026 Financial Results [Yahoo! Finance]Yahoo! Finance
- Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2026 Financial ResultsBusiness Wire
- Cryo-Cell Receives NYSE American Continued Listing Notice [Yahoo! Finance]Yahoo! Finance
- Cryo-Cell Receives NYSE American Continued Listing NoticeBusiness Wire
- CRYO-CELL International GAAP EPS of -$0.30 misses by $0.37, revenue of $31.6M beats by $0.1M [Seeking Alpha]Seeking Alpha
CCEL
Sec Filings
- 4/14/26 - Form 10-Q
- 3/25/26 - Form SCHEDULE
- 3/12/26 - Form 8-K
- CCEL's page on the SEC website